Vertex Pharmaceuticals Incorporated VRTX
533.65 USD -19.50 (-3.53%)
Nov 3, 2026, 3:17 PM EST
531.68 Day range 561.96
409.47 52-week range 558.88
- YTD
- +17.71%
- 1 year
- +25.27%
Analyst view
Consensus: buy
Buy
Price target (mean) 571.46 +7.1% upside
Now 533.65
- Target (low)
- 350.00
- Target (mean)
- 571.46
- Target (high)
- 667.00
Ratings (0m) 32 26 buy · 4 hold · 2 sell
- Strong buy6
- Buy20
- Hold4
- Sell1
- Strong sell1
Recommendation trend
- This month 32
- 1 month ago 32
- 2 months ago 29
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.78 | 3.68 – 5.25 | 4.80 | -0.3% | 3.43B | +11.7% | 13 |
| Next quarter | 4.64 | 4.04 – 5.22 | 5.03 | -7.7% | 3.53B | +10.7% | 16 |
| Current year | 18.77 | 17.61 – 19.54 | 18.40 | +2.0% | 13.28B | +10.7% | 17 |
| Next year | 20.42 | 17.86 – 23.06 | 18.77 | +8.8% | 14.60B | +9.9% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 28, 2026 | UBS | Maintained | Buy | Buy |
| Aug 5, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 4, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 13, 2026 | UBS | Maintained | Buy | Buy |
| Jul 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 7, 2026 | Baird | Maintained | Underperform | Underperform |
| May 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 5, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 5, 2026 | Bernstein | Maintained | Outperform | Outperform |
| May 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 30, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 18, 2026 | Maxim Group | Upgrade | Hold | Buy |
| Mar 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 10, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 10, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Jefferies | Initiated | — | Buy |
| Mar 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 17, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 17, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 13, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
